Literature DB >> 33691641

Association between physical performance and incidence of end-stage renal disease in older adults: a national wide cohort study.

Hee-Won Jung1, In Young Choi2, Dong Wook Shin3,4, Kyungdo Han5, Jung Eun Yoo6, Sohyun Chun7, Yongjin Yi8.   

Abstract

BACKGROUND: Physical frailty has previously been associated with adverse clinical outcomes in patients with end-stage renal disease (ESRD). This study aimed to determine whether impaired physical performance at baseline is associated with the incidence of ESRD, using a nationwide database.
METHODS: The timed up-and-go (TUG) test was used to assess physical frailty in 1,552,781 66-year-old individuals, using health examination database records from the Korean National Health Insurance Service. As a primary endpoint, incident ESRD was defined operationally using healthcare claims data from the Korean Health Insurance Review and Assessment Service.
RESULTS: Our results showed that baseline kidney function was significantly worse in individuals with TUG results of > 10 s compared to individuals with an intact TUG performance (≤10 s). Kaplan-Meier analysis showed a stepwise dose-response relationship between baseline physical performance and the incidence rate of ESRD (log-rank test P-value of < 0.001). An increasing ESRD incidence rate trend with poor physical performance remained significant after adjusting for characteristics such as baseline glomerular filtration rate and proteinuria.
CONCLUSION: Poor baseline physical performance was associated with an increased risk of ESRD, suggesting possible interactions between systemic frailty and vascular aging processes.

Entities:  

Keywords:  Chronic kidney disease; Frailty; Morbidity; Physical function

Mesh:

Year:  2021        PMID: 33691641      PMCID: PMC7945335          DOI: 10.1186/s12882-021-02291-4

Source DB:  PubMed          Journal:  BMC Nephrol        ISSN: 1471-2369            Impact factor:   2.388


  42 in total

1.  Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study.

Authors:  Jeremy Walston; Mary Ann McBurnie; Anne Newman; Russell P Tracy; Willem J Kop; Calvin H Hirsch; John Gottdiener; Linda P Fried
Journal:  Arch Intern Med       Date:  2002-11-11

Review 2.  Chronic kidney disease: a clinical model of premature aging.

Authors:  Peter Stenvinkel; Tobias E Larsson
Journal:  Am J Kidney Dis       Date:  2013-01-26       Impact factor: 8.860

3.  Cerebral White Matter and Slow Gait: Contribution of Hyperintensities and Normal-appearing Parenchyma.

Authors:  Bedda L Rosario; Andrea L Rosso; Howard J Aizenstein; Tamara Harris; Anne B Newman; Suzanne Satterfield; Stephanie A Studenski; Kristine Yaffe; Caterina Rosano
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-01-11       Impact factor: 6.053

4.  Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.

Authors:  Ankit Sutaria; Longjian Liu; Ziauddin Ahmed
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-02-25

5.  Association between physical activity and kidney function: National Health and Nutrition Examination Survey.

Authors:  Marquis S Hawkins; Mary Ann Sevick; Caroline R Richardson; Linda F Fried; Vincent C Arena; Andrea M Kriska
Journal:  Med Sci Sports Exerc       Date:  2011-08       Impact factor: 5.411

6.  Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Shoshana H Ballew; Yan Chen; Natalie R Daya; Job G Godino; B Gwen Windham; Mara McAdams-DeMarco; Josef Coresh; Elizabeth Selvin; Morgan E Grams
Journal:  Am J Kidney Dis       Date:  2016-11-22       Impact factor: 8.860

7.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

Review 8.  Frailty in elderly people.

Authors:  Andrew Clegg; John Young; Steve Iliffe; Marcel Olde Rikkert; Kenneth Rockwood
Journal:  Lancet       Date:  2013-02-08       Impact factor: 79.321

Review 9.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

Authors:  Claudio Franceschi; Judith Campisi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06       Impact factor: 6.053

10.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

View more
  1 in total

1.  Accelerated epigenetic aging and inflammatory/immunological profile (ipAGE) in patients with chronic kidney disease.

Authors:  Igor Yusipov; Elena Kondakova; Alena Kalyakulina; Mikhail Krivonosov; Nadezhda Lobanova; Maria Giulia Bacalini; Claudio Franceschi; Maria Vedunova; Mikhail Ivanchenko
Journal:  Geroscience       Date:  2022-03-02       Impact factor: 7.581

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.